Stay updated with breaking news from Novel Class. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The use of flow chemistry to generate compound libraries for screening against a biological target enables faster exploration of potential drug candidates, accelerating early drug discovery projects. Click to read more...
/PRNewswire/ -- MAPS Public Benefit Corporation ("MAPS PBC"), a company dedicated to transforming mental healthcare, announced an oversubscribed Series A...
Arguably the most impressive mover yesterday was a stock you have probably never heard of. Shares of Eloxx Pharmaceuticals (NASDAQ:ELOX) rocketed almost 100% yesterday
Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) shares are rocketing higher on Tuesday after Oppenheimer raised its price target from $50 to $55.
Shares of Eloxx Pharmaceuticals, Inc. (ELOX) are surging over 110% on Tuesday morning after its price target was raised by analysts at Oppenheimer Holdings Inc. from $50.